Anondita Medicare Ipo
Objects of the Issue
Funding capital expenditure requirements for the purchase of equipment/machineries
Funding the Working Capital requirement
Unidentified Acquisition and General Corporate Purposes
Anondita Medicare IPO Review
Canara Bank –
DRChoksey FinServ –
Emkay Global –
Hem Securities –
IDBI Capital –
Marwadi Shares –
Nirmal Bang –
SBICAP Securities –
Sharekhan –
SMC Global –
Sushil Finance –
Swastika Investmart –
Ventura Securities –
Geojit –
Reliance Securities –
Capital Market –
BP Wealth –
ICICIdirect –
Choice Broking –
IPO Lead Managers aka Merchant Bankers
Narnolia Financial Services Ltd.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 2 | 2,000 | ₹2,90,000 |
| Retail Maximum | 2 | 2,000 | ₹2,90,000 |
| S-HNI Minimum | 3 | 3,000 | ₹4,35,000 |
| B-HNI Minimum | 7 | 7,000 | ₹10,15,000 |
| IPO Open Date: | August 22, 2025 |
| IPO Close Date: | August 26, 2025 |
| Basis of Allotment: | August 28, 2025 |
| Refunds: | August 29, 2025 |
| Credit to Demat Account: | August 29, 2025 |
| IPO Listing Date: | September 1, 2025 |
| Period Ended | Revenue | Expense | Profit After Tax | Assets |
| 2023 | ₹36.14 | ₹35.67 | ₹0.35 | ₹37.80 |
| 2024 | ₹46.56 | ₹41.40 | ₹3.84 | ₹42.92 |
| 2025 | ₹77.13 | ₹55.18 | ₹16.42 | ₹78.27 |
| KPI | Values |
| ROE: | 41.71% |
| ROCE: | 37.42% |
| EBITDA Margin: | 33.32% |
| PAT Margin: | 21.32% |
| Debt to equity ratio: | 0.97 |
| Earning Per Share (EPS): | ₹9.60 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 38.10% |
| Net Asset Value (NAV): | ₹21.32 |
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
| Cupid Limited | 1.52 | 110.38 | 11.96 | 12.75 | 40.93 Cr. |
| IPO Open Date: | August 22, 2025 |
| IPO Close Date: | August 26, 2025 |
| Face Value: | ₹10 Per Equity Share |
| IPO Price Band: | ₹137 to ₹145 Per Share |
| Issue Size: | Approx ₹69.50 Crores |
| Fresh Issue: | Approx ₹69.50 Crores |
| Lot Size: | 1,000 Shares |
| Issue Type: | Book Built Issue |
| IPO Listing: | NSE SME |
| Retail Quota: | Not more than 35% |
| QIB Quota: | Not more than 50% |
| NII Quota: | Not more than 15% |
| DRHP Draft Prospectus: | Click Here |
| RHP Draft Prospectus: | Click Here |
| Anchor Investors List: | Click Here |